FibroGen (FGEN) Tops Q3 EPS by 21c

November 8, 2016 4:05 PM EST

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.38), $0.21 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $30.1 million versus the consensus estimate of $24.3 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities